Aspirin: still learning about the wonder drug.
Hawk
E T
ET
National Cancer Institute, Division of Cancer Prevention, Bethesda, MD 20892, USA. eh51p@nih.gov
Viner
J L
JL
D000236:Adenoma / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D016588:Anticarcinogenic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000517:prevention & control*; D004334:Drug Administration Schedule; D006801:Humans; D011230:Precancerous Conditions / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016588:Anticarcinogenic Agents; D001241:Aspirin